Effectiveness and Safety of Arimoclomol for the Treatment of Neurological Manifestations of Niemann-Pick Disease Type C: A Review of Clinical Trial Data
Advertisement
Advertisement
Trending on AJMC
1
Iron Dysregulation Linked to MS Progression, Review Finds
2
FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC
3
FDA Approves Ruxolitinib Cream for Patients as Young as 2 Years With Atopic Dermatitis
4
Second Known Case of Concurrent ET, WM Raises Questions About Their Coexistence
5
